Psychedelic Assisted Therapy: Ketamine vs MDMA vs Psilocybin

Back from the Abyss: Psychiatry in Stories

Craig Heacock MD

Psychiatry, Bipolar, Suicide, Depression, Ketamine, Psychotherapy, Science, Psychedelics, Health & Fitness, Addiction, Medicine, Psychology, Mental Health

4.8 • 452 Ratings

🗓️ 23 March 2023

⏱️ 82 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

Dr. H explores how to think about psychedelic assisted therapy with ketamine, MDMA, and psilocybin in terms of patient selection, ideal indications, psychiatric diagnosis, trauma history, medical comorbidities, medication interactions, cautions, and contraindications. This episode comes from a recent interview that Dr. H did on the podcast The Testing Psychologist."The Unwell Doctor" episode on the podcast The Nocturnistshttps://www.thenocturnists-shame.org/episodes/9-the-unwell-doctorB...

Transcript

Click on a timestamp to play from that location

0:00.0	Welcome to Back from the Abyss. I'm Dr. Craig Hecock. I just finished listening to a really beautiful series on the podcast, The Nocturnus.
0:23.5	It's an eight or ten part series on shame and medicine, and there was one episode called
0:28.3	The Unwell Doctor, which I was really moved by, and I'm going to link to that in the show
0:32.9	notes, because I think back from the abyss listeners might find it really powerful.
0:38.6	Well, today's episode is a recent interview I did with Dr. Jeremy Sharp on his podcast,
0:43.7	The Testing Psychologist.
0:45.2	And I thought it would be of interest to Back from the Abyss listeners.
0:48.1	So Chris and I did a little editing and added some music and voila.
0:53.0	Here we go.
0:59.3	Craig, welcome back to the testing psychologist podcast oh it's great to be here thanks Jeremy yes yes I'm glad to be here with you our last episode
1:04.4	on substance induced psychosis talking specifically about THC super popular and super important and the mental health landscape these days.
1:13.7	But we're going to dive into psychedelic assisted treatment, which is also huge right now and more on the helpful side than the hurtful side, I suppose.
1:24.0	So grateful to have you.
1:25.7	And I'm excited to dive in.
1:28.8	Yeah, me too. Thanks for having me. Absolutely. We're going to dive into specific treatments, right? We're going to do psilocybin,
1:34.6	ketamine, and MDMA during the podcast. But I want to ask a broad question since you're bringing
1:41.4	it up here at the beginning. I immediately think, okay, how is this,
1:47.6	how do we separate the healing or the journey that happens with these interventions from
1:53.7	either placebo effect or some kind of memory placement, you know, like that we're sort of unduly influencing clients to remember
2:04.7	things that may or may not be there.
2:06.7	It seems like that's a really fine line to walk with some of this treatment.
2:11.1	Am I off on that?
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Craig Heacock MD, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Craig Heacock MD and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.